Global Lentiviral Expression Systems 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08253249

Publication Date:

August 19, 2024

Pages:

107

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Lentiviral are vectors that are derived from the virus known as human immunodeficiency virus and is used to transfer gene in the cells, such as mammalian cell and Others. Lentiviruses are used for transfection in non-dividing and actively dividing cell. This acts as an advantage to anOthers type of retrovirus. The lentiviruses fall in the category of a retrovirus. The lentiviral expression system is developed, which can influence the gene of interest. The commercially available lentiviral expression systems are available in combination with tag sequence, reporter gene, promoters and multicistronic vectors are also available for desired protein expression. These vectors are used for research and development purpose recombinant protein expression, protein characterization, in-vitro transcription, and Others functional arrays.
The global Lentiviral Expression Systems market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The 鈥淟entiviral Expression Systems Industry Forecast鈥� looks at past sales and reviews total world Lentiviral Expression Systems sales in 2023, providing a comprehensive analysis by region and market sector of projected Lentiviral Expression Systems sales for 2024 through 2030. With Lentiviral Expression Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lentiviral Expression Systems industry.
This Insight Report provides a comprehensive analysis of the global Lentiviral Expression Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lentiviral Expression Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Lentiviral Expression Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lentiviral Expression Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lentiviral Expression Systems.
Based on the expression system components, global lentiviral expression system market is segmented lentiviral promoter, which is further sub-segmented as lentivirus promoter vectors, lentivirus promoterless vectors, lentiviral fusion tags lentivirus packaging systems and Others accessories. Based on the application type, global lentiviral expression system market is segmented as recombinant protein expression, functional assays, protein characterization, In vitro transcription and Others application for research and study purpose. On the basis of end user, the global lentiviral expression system market is segmented into biotechnological companies, pharmaceutical companies, contract research organizations, academic/ research institutes.
This report presents a comprehensive overview, market shares, and growth opportunities of Lentiviral Expression Systems market by product type, application, key players and key regions and countries.
Segmentation by type
Lentiviral Promoter
Lentiviral Fusion Tags
Lentivirus Packaging Systems
Others
Segmentation by application
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations
Academic/Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Dharmacon
Thermo Fisher Scientific
Merck KGaA
Takara Bio
ABM Industries
Cell Biolabs
GeneCopoeia
System Biosciences
Fujifilm Diosynth Biotechnologies
ATUM

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Lentiviral Expression Systems 麻豆原创 Size 2019-2030
2.1.2 Lentiviral Expression Systems 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Lentiviral Expression Systems Segment by Type
2.2.1 Lentiviral Promoter
2.2.2 Lentiviral Fusion Tags
2.2.3 Lentivirus Packaging Systems
2.2.4 Others
2.3 Lentiviral Expression Systems 麻豆原创 Size by Type
2.3.1 Lentiviral Expression Systems 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Lentiviral Expression Systems 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Lentiviral Expression Systems Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Contract Research Organizations
2.4.4 Academic/Research Institutes
2.4.5 Others
2.5 Lentiviral Expression Systems 麻豆原创 Size by Application
2.5.1 Lentiviral Expression Systems 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Lentiviral Expression Systems 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Lentiviral Expression Systems 麻豆原创 Size by Player
3.1 Lentiviral Expression Systems 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Lentiviral Expression Systems Revenue by Players (2019-2024)
3.1.2 Global Lentiviral Expression Systems Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Lentiviral Expression Systems Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lentiviral Expression Systems by Regions
4.1 Lentiviral Expression Systems 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Lentiviral Expression Systems 麻豆原创 Size Growth (2019-2024)
4.3 APAC Lentiviral Expression Systems 麻豆原创 Size Growth (2019-2024)
4.4 Europe Lentiviral Expression Systems 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Lentiviral Expression Systems 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Lentiviral Expression Systems 麻豆原创 Size by Country (2019-2024)
5.2 Americas Lentiviral Expression Systems 麻豆原创 Size by Type (2019-2024)
5.3 Americas Lentiviral Expression Systems 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lentiviral Expression Systems 麻豆原创 Size by Region (2019-2024)
6.2 APAC Lentiviral Expression Systems 麻豆原创 Size by Type (2019-2024)
6.3 APAC Lentiviral Expression Systems 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lentiviral Expression Systems by Country (2019-2024)
7.2 Europe Lentiviral Expression Systems 麻豆原创 Size by Type (2019-2024)
7.3 Europe Lentiviral Expression Systems 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lentiviral Expression Systems by Region (2019-2024)
8.2 Middle East & Africa Lentiviral Expression Systems 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Lentiviral Expression Systems 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Lentiviral Expression Systems 麻豆原创 Forecast
10.1 Global Lentiviral Expression Systems Forecast by Regions (2025-2030)
10.1.1 Global Lentiviral Expression Systems Forecast by Regions (2025-2030)
10.1.2 Americas Lentiviral Expression Systems Forecast
10.1.3 APAC Lentiviral Expression Systems Forecast
10.1.4 Europe Lentiviral Expression Systems Forecast
10.1.5 Middle East & Africa Lentiviral Expression Systems Forecast
10.2 Americas Lentiviral Expression Systems Forecast by Country (2025-2030)
10.2.1 United States Lentiviral Expression Systems 麻豆原创 Forecast
10.2.2 Canada Lentiviral Expression Systems 麻豆原创 Forecast
10.2.3 Mexico Lentiviral Expression Systems 麻豆原创 Forecast
10.2.4 Brazil Lentiviral Expression Systems 麻豆原创 Forecast
10.3 APAC Lentiviral Expression Systems Forecast by Region (2025-2030)
10.3.1 China Lentiviral Expression Systems 麻豆原创 Forecast
10.3.2 Japan Lentiviral Expression Systems 麻豆原创 Forecast
10.3.3 Korea Lentiviral Expression Systems 麻豆原创 Forecast
10.3.4 Southeast Asia Lentiviral Expression Systems 麻豆原创 Forecast
10.3.5 India Lentiviral Expression Systems 麻豆原创 Forecast
10.3.6 Australia Lentiviral Expression Systems 麻豆原创 Forecast
10.4 Europe Lentiviral Expression Systems Forecast by Country (2025-2030)
10.4.1 Germany Lentiviral Expression Systems 麻豆原创 Forecast
10.4.2 France Lentiviral Expression Systems 麻豆原创 Forecast
10.4.3 UK Lentiviral Expression Systems 麻豆原创 Forecast
10.4.4 Italy Lentiviral Expression Systems 麻豆原创 Forecast
10.4.5 Russia Lentiviral Expression Systems 麻豆原创 Forecast
10.5 Middle East & Africa Lentiviral Expression Systems Forecast by Region (2025-2030)
10.5.1 Egypt Lentiviral Expression Systems 麻豆原创 Forecast
10.5.2 South Africa Lentiviral Expression Systems 麻豆原创 Forecast
10.5.3 Israel Lentiviral Expression Systems 麻豆原创 Forecast
10.5.4 Turkey Lentiviral Expression Systems 麻豆原创 Forecast
10.5.5 GCC Countries Lentiviral Expression Systems 麻豆原创 Forecast
10.6 Global Lentiviral Expression Systems Forecast by Type (2025-2030)
10.7 Global Lentiviral Expression Systems Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Dharmacon
11.1.1 Dharmacon Company Information
11.1.2 Dharmacon Lentiviral Expression Systems Product Offered
11.1.3 Dharmacon Lentiviral Expression Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Dharmacon Main Business Overview
11.1.5 Dharmacon Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Lentiviral Expression Systems Product Offered
11.2.3 Thermo Fisher Scientific Lentiviral Expression Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Lentiviral Expression Systems Product Offered
11.3.3 Merck KGaA Lentiviral Expression Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Takara Bio
11.4.1 Takara Bio Company Information
11.4.2 Takara Bio Lentiviral Expression Systems Product Offered
11.4.3 Takara Bio Lentiviral Expression Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Takara Bio Main Business Overview
11.4.5 Takara Bio Latest Developments
11.5 ABM Industries
11.5.1 ABM Industries Company Information
11.5.2 ABM Industries Lentiviral Expression Systems Product Offered
11.5.3 ABM Industries Lentiviral Expression Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 ABM Industries Main Business Overview
11.5.5 ABM Industries Latest Developments
11.6 Cell Biolabs
11.6.1 Cell Biolabs Company Information
11.6.2 Cell Biolabs Lentiviral Expression Systems Product Offered
11.6.3 Cell Biolabs Lentiviral Expression Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Cell Biolabs Main Business Overview
11.6.5 Cell Biolabs Latest Developments
11.7 GeneCopoeia
11.7.1 GeneCopoeia Company Information
11.7.2 GeneCopoeia Lentiviral Expression Systems Product Offered
11.7.3 GeneCopoeia Lentiviral Expression Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 GeneCopoeia Main Business Overview
11.7.5 GeneCopoeia Latest Developments
11.8 System Biosciences
11.8.1 System Biosciences Company Information
11.8.2 System Biosciences Lentiviral Expression Systems Product Offered
11.8.3 System Biosciences Lentiviral Expression Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 System Biosciences Main Business Overview
11.8.5 System Biosciences Latest Developments
11.9 Fujifilm Diosynth Biotechnologies
11.9.1 Fujifilm Diosynth Biotechnologies Company Information
11.9.2 Fujifilm Diosynth Biotechnologies Lentiviral Expression Systems Product Offered
11.9.3 Fujifilm Diosynth Biotechnologies Lentiviral Expression Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Fujifilm Diosynth Biotechnologies Main Business Overview
11.9.5 Fujifilm Diosynth Biotechnologies Latest Developments
11.10 ATUM
11.10.1 ATUM Company Information
11.10.2 ATUM Lentiviral Expression Systems Product Offered
11.10.3 ATUM Lentiviral Expression Systems Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 ATUM Main Business Overview
11.10.5 ATUM Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.